Information
-
Trademark
-
98199140
-
International Classifications
-
Filing Date
September 27, 2023
2 years ago
-
Transaction Date
May 06, 2025
8 months ago
-
Status Date
May 05, 2025
8 months ago
-
Published for Opposition Date
April 02, 2024
a year ago
-
Location Date
June 04, 2024
a year ago
-
Status Code
731
-
Current Location
INTENT TO USE SECTION
Employee Name
POLZER, NATALIE
-
Attorney Docket Number
034845.303B
Attorney Name
Scott D. Woldow
Law Office Assigned Location Code
L80
-
Owners
Mark Drawing Code
4
Mark Identification
KYVIVY
Case File Statements
- GS0051: Pharmaceutical preparations for the treatment of blood conditions; Pharmaceutical preparations for the treatment of transplant diseases, illnesses, and conditions; Pharmaceutical preparations for renal transplant diseases, illnesses, and conditions; Pharmaceutical preparations for kidney diseases, illnesses and conditions; Pharmaceutical preparations for treatment of antibody mediated rejection in adult renal transplant recipients; pharmaceutical preparations to treat hematology diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of emphysema diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, acute respiratory distress syndrome, ARDS; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations for the treatment of respiratory diseases, illnesses and conditions, namely, antibody for the treatment of Hereditary Angioedema, HAE; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions, namely, Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations for the treatment of lung diseases, illnesses and conditions, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD
Case File Event Statements
-
9/30/2023 - 2 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
2/20/2024 - a year ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
10/11/2023 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
2/16/2024 - a year ago
3 - TEAS VOLUNTARY AMENDMENT RECEIVED
Type: PARI
-
2/26/2024 - a year ago
5 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/2/2024 - a year ago
8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/13/2024 - a year ago
6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
4/2/2024 - a year ago
7 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/4/2024 - a year ago
9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
11/4/2024 - a year ago
10 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
11/4/2024 - a year ago
13 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
11/4/2024 - a year ago
11 - SOU EXTENSION 1 FILED
Type: EXT1
-
11/4/2024 - a year ago
12 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
5/5/2025 - 8 months ago
14 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
5/5/2025 - 8 months ago
15 - SOU EXTENSION 2 FILED
Type: EXT2
-
5/5/2025 - 8 months ago
16 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
5/5/2025 - 8 months ago
17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA